• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Feasibility and short-term efficacy of simplified intensity-modulated radiotherapy and concurrent chemotherapy for neck and upper thoracic esophageal carcinoma].

作者信息

Zhu Wei-Guo, Yu Chang-Hua, Han Ji-Hua, Li Tao, Zhou Xi-Lei, Tao Guang-Zhou

机构信息

Department of Radiation Oncology,Huai'an First People's Hospital, Huai'an, Jiangsu, 223300,P. R. China.

出版信息

Ai Zheng. 2009 Dec;28(12):1265-9. doi: 10.5732/cjc.009.10215.

DOI:10.5732/cjc.009.10215
PMID:19958620
Abstract

BACKGROUND AND OBJECTIVE

For neck and upper thoracic esophageal carcinoma, three dimensional conformal radiation therapy (3D-CRT) does not necessarily meet all clinical requirements while intensity modulated radiation therapy (IMRT) may take up a lot of labour power and material resources. This study was to explore the feasibility of simplified IMPT(sIMRT) and concurrent chemotherapy for neck and upper thoracic esophageal carcinoma, and to investigate the acute toxicities and short-term efficacy of this treatment modality.

METHODS

sIMRT plans were designed for 30 patients with neck and upper thoracic esophageal carcinoma. Two target volumes were defined: PTV1, which was designed to irradiate to 64 Gy (2.13 Gy x 30 fractions); PTV2, which was given to 54 Gy (1.8 Gy x 30). The sIMRT plan included five equiangular coplanar beams. All patients concurrently received DDP+5-FU regimen with radiotherapy on d1-5 and d29-33. Chemotherapy was repeated for two cycles 28 days after radiotherapy.

RESULTS

The treatment was completed for all patients within 6 weeks, and only one patient had Grade 3 acute bronchitis. The complete response (CR) rate was 90.0% (27/30) and the partial response (PR) rate 10.0% (3/30). Overall response was 100% for esophageal lesions and the CR rate 76.5% (13/17). The PR rate was 23.5% (4/17) in lymph node lesions. The major toxicities observed were Grades I-II leukocytopenia.

CONCLUSIONS

sIMRT can generate desirable dose distribution for neck and upper thoracic esophageal carcinoma, which is similar to sophisticated IMRT but obviously better than 3D-CRT. The short-term efficacy of sIMRT is satisfactory and its acute toxicities are tolerable.

摘要

相似文献

1
[Feasibility and short-term efficacy of simplified intensity-modulated radiotherapy and concurrent chemotherapy for neck and upper thoracic esophageal carcinoma].
Ai Zheng. 2009 Dec;28(12):1265-9. doi: 10.5732/cjc.009.10215.
2
Efficacy analysis of simplified intensity-modulated radiotherapy with high or conventional dose and concurrent chemotherapy for patients with neck and upper thoracic esophageal carcinoma.简化调强放疗高剂量或常规剂量联合同步化疗治疗颈段和胸上段食管癌患者的疗效分析
Asian Pac J Cancer Prev. 2012;13(3):803-7. doi: 10.7314/apjcp.2012.13.3.803.
3
Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.新辅助同步放化疗后行根治性高剂量放疗或手术治疗可切除的胸段食管癌。
Int J Radiat Oncol Biol Phys. 1998 Mar 15;40(5):1049-59. doi: 10.1016/s0360-3016(97)00900-0.
4
[Phase II clinical trial of concurrent chemoradiotherapy (cisplatin plus 5-fluorouracil) for esophageal cancer].[顺铂联合5-氟尿嘧啶同步放化疗治疗食管癌的II期临床试验]
Ai Zheng. 2008 Oct;27(10):1077-81.
5
Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus.食管T4和/或M1淋巴结鳞状细胞癌的根治性放化疗。
J Clin Oncol. 1999 Sep;17(9):2915-21. doi: 10.1200/JCO.1999.17.9.2915.
6
Dosimetric comparison between step-shoot intensity-modulated radiotherapy and volumetric-modulated arc therapy for upper thoracic and cervical esophageal carcinoma.上胸段和颈段食管癌的步进-射野调强放疗与容积调强弧形放疗的剂量学比较
Med Dosim. 2016 Summer;41(2):131-5. doi: 10.1016/j.meddos.2015.10.007. Epub 2016 Feb 23.
7
Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.在可切除食管癌新辅助放化疗的两个化疗周期中,每日两次放疗作为同步推量技术:II期研究的成熟结果
Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):111-22. doi: 10.1016/j.ijrobp.2004.03.031.
8
Phase II study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and pemetrexed and cisplatin for locally advanced oesophageal squamous cell carcinoma.同步选择性淋巴结晚期加速超分割放疗联合培美曲塞和顺铂治疗局部晚期食管鳞状细胞癌的II期研究
Br J Radiol. 2014 May;87(1037):20130656. doi: 10.1259/bjr.20130656. Epub 2014 Mar 26.
9
Long-term clinical outcome of intensity-modulated radiation therapy for locally advanced esophageal squamous cell carcinoma.调强放射治疗局部晚期食管鳞状细胞癌的长期临床疗效
Tumori. 2015 Mar-Apr;101(2):168-73. doi: 10.5301/tj.5000234. Epub 2015 Mar 16.
10
[Dosimetric comparison between intensity-modulated radiotherapy and conformal radiotherapy for upper thoracic esophageal carcinoma].[胸段上段食管癌调强放疗与适形放疗的剂量学比较]
Ai Zheng. 2009 Nov;28(11):1127-31. doi: 10.5732/cjc.008.10839.

引用本文的文献

1
Clinical results of intensity-modulated radiotherapy for 250 patients with cervical and upper thoracic esophageal carcinoma.250例颈段和胸上段食管癌患者调强放疗的临床结果
Cancer Manag Res. 2019 Sep 10;11:8285-8294. doi: 10.2147/CMAR.S203575. eCollection 2019.